Lesson plan
Azumio
Azumio ( ) is a mobile health company that specializes in biometric mobile technology. Founded in 2011, Azumio develops Apple iOS and Android health apps and services. Azumio has released 24 apps on iOS, 5 apps on Android, and 3 apps on Windows Phone. The company is headquartered in Palo Alto, California.
Article summary
Azumio ( ) is a mobile health company that specializes in biometric mobile technology. Founded in 2011, Azumio develops Apple iOS and Android health apps and services. Azumio has released 24 apps on iOS, 5 apps on Android, and 3 apps on Windows Phone. The company is headquartered in Palo Alto, California.
Key claims
- date of foundation: 2011 — source: Wikipedia, revision 1376121789, retrieved 2026-10-20 · confidence 0.95
- release date: 2010 — source: Wikipedia, revision 1376121789, retrieved 2026-10-20 · confidence 0.95
- release date: 2012-03-28 — source: Wikipedia, revision 1376121789, retrieved 2026-10-20 · confidence 0.95
- release date: 2011 — source: Wikipedia, revision 1376121789, retrieved 2026-10-20 · confidence 0.95
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- The record states that the date of foundation is "2011". What evidence would count against this claim?
- The record states that the release date is "2010". What evidence would count against this claim?
- The record states that the release date is "2012-03-28". What evidence would count against this claim?
- The record states that the release date is "2011". What evidence would count against this claim?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
- Wikipedia, “Azumio”, revision 1376121789, retrieved 2026-10-20 https://en.wikipedia.org/w/index.php?oldid=1376121789
Key claims and bibliography are generated from the same tracked claims and sources as the article page.